MROPF
Price
$0.13
Change
-$0.20 (-60.61%)
Updated
Sep 25 closing price
OLYMY
Price
$15.37
Change
+$0.02 (+0.13%)
Updated
Dec 17 closing price
Ad is loading...

MROPF vs OLYMY

Header iconMROPF vs OLYMY Comparison
Open Charts MROPF vs OLYMYBanner chart's image
MICROPORT CARDIOFLOW MEDTECH
Price$0.13
Change-$0.20 (-60.61%)
Volume$100
CapitalizationN/A
Olympus
Price$15.37
Change+$0.02 (+0.13%)
Volume$66.62K
CapitalizationN/A
MROPF vs OLYMY Comparison Chart
Loading...
OLYMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MROPF vs. OLYMY commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MROPF is a Hold and OLYMY is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (MROPF: $0.13 vs. OLYMY: $15.37)
Brand notoriety: MROPF and OLYMY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MROPF: 100% vs. OLYMY: 86%
Market capitalization -- MROPF: $695.4M vs. OLYMY: $20.63B
MROPF [@Medical Specialties] is valued at $695.4M. OLYMY’s [@Medical Specialties] market capitalization is $20.63B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MROPF’s FA Score shows that 1 FA rating(s) are green whileOLYMY’s FA Score has 1 green FA rating(s).

  • MROPF’s FA Score: 1 green, 4 red.
  • OLYMY’s FA Score: 1 green, 4 red.
According to our system of comparison, OLYMY is a better buy in the long-term than MROPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OLYMY’s TA Score shows that 4 TA indicator(s) are bullish.

  • OLYMY’s TA Score: 4 bullish, 2 bearish.

Price Growth

MROPF (@Medical Specialties) experienced а 0.00% price change this week, while OLYMY (@Medical Specialties) price change was -1.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.17%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was -0.66%.

Reported Earning Dates

OLYMY is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Medical Specialties (-4.17% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OLYMY($20.6B) has a higher market cap than MROPF($695M). OLYMY YTD gains are higher at: 7.840 vs. MROPF (-60.818). OLYMY has higher annual earnings (EBITDA): 257B vs. MROPF (-118.59M). OLYMY has more cash in the bank: 181B vs. MROPF (2.21B). MROPF has less debt than OLYMY: MROPF (126M) vs OLYMY (340B). OLYMY has higher revenues than MROPF: OLYMY (882B) vs MROPF (201M).
MROPFOLYMYMROPF / OLYMY
Capitalization695M20.6B3%
EBITDA-118.59M257B-0%
Gain YTD-60.8187.840-776%
P/E RatioN/A20.88-
Revenue201M882B0%
Total Cash2.21B181B1%
Total Debt126M340B0%
TECHNICAL ANALYSIS
Technical Analysis
MROPFOLYMY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
2%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
N/A
Bearish Trend 2 days ago
50%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
65%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
54%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
51%
View a ticker or compare two or three
Ad is loading...
OLYMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HQIFX20.12-0.12
-0.59%
Hartford Equity Income F
QRLVX31.43-0.20
-0.63%
Federated Hermes MDT Large Cap Value R
ASGCX12.13-0.08
-0.66%
Allspring Global Long/Short Equity C
BMPIX108.27-0.87
-0.80%
ProFunds Materials UltraSector Inv
CSCJX15.97-0.18
-1.11%
CornerCap Small-Cap Value Institutional

MROPF and

Correlation & Price change

A.I.dvisor tells us that MROPF and MEDP have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MROPF and MEDP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MROPF
1D Price
Change %
MROPF100%
N/A
MEDP - MROPF
26%
Poorly correlated
-0.36%
SAFLF - MROPF
21%
Poorly correlated
N/A
STSS - MROPF
9%
Poorly correlated
-2.83%
PRE - MROPF
8%
Poorly correlated
-0.17%
OLYMY - MROPF
4%
Poorly correlated
+0.11%
More

OLYMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLYMY has been loosely correlated with OCPNF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OLYMY jumps, then OCPNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLYMY
1D Price
Change %
OLYMY100%
+0.11%
OCPNF - OLYMY
42%
Loosely correlated
N/A
TRUMY - OLYMY
42%
Loosely correlated
-0.20%
MTD - OLYMY
35%
Loosely correlated
-1.10%
SSMXY - OLYMY
34%
Loosely correlated
+0.31%
HOCPY - OLYMY
33%
Loosely correlated
+1.01%
More